Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
To determine the safety profile of sodium fluorescein in women undergoing cystoscopy during
gynecologic surgery. To determine if either oral phenazopyridine or sodium fluorescein result
in shorter cystoscopy times.
Phase:
N/A
Details
Lead Sponsor:
University Hospitals Cleveland Medical Center
Collaborators:
Alex Soriano Graham Chapman Megan Billow Sangeeta Mahajan Sherif El-Nashar